Back to catalog

Product details

ARA-290

$34.99$49.9910mg · per unit

Save $15.00 per unit with current offers

Explore ARA-290 amounts, pricing, and product information.

Front view of ARA-290
ARA-29010mgRESEARCH USE ONLY
-30%

Select your product

Amount
Bundle and save

Bundle savings apply after the sale price. Same product and amount: 2–3 bottles save 3% extra, 4–10 save 6%, and 11+ save 30%.

10mg · 1 unit · Total

$34.99$49.99

$34.99 per unit

Save $15.00 total

WINTER30 −30%

Save your selection in the cart. Ordering is not open. Contact us for availability.

For laboratory research only. Not for human or veterinary use. Research-use policy.

Know your compound

Compound information

ARA-290

ARA-290 is indexed under Cibinetide in PubChem.

Identity references 1 source
Catalog identity
ARA-290
Intended use
Laboratory research
Research names
ARA 290
Reference molecule
Cibinetide
PubChem record
CID 91810664
Molecular formula
C51H84N16O21
Molecular weight
1257.3 g/mol

Molecular data describe the reference compound in PubChem, not a laboratory analysis of this product or batch.

Primary literature

Verified research references

Primary-source bibliography for the named compound. These studies did not test this catalog item.

Randomized human research included

ARA-2902 verified references

Identity note

The cited papers use "ARA 290"; "ARA-290" is a punctuation-normalized catalog label only, and the name match does not establish that the catalog material is the study material.

  1. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.

    Heij L · 2012 · Mol Med

    Study design
    Randomized controlled trial
    Research context
    Human research
    Sample size
    22 participants or samples
    Study population
    Patients with confirmed sarcoidosis and symptoms consistent with small-fiber neuropathy

    PMID: 23168581

    DOI: 10.2119/molmed.2012.00332

  2. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.

    Dahan A · 2013 · Mol Med

    Study design
    Randomized controlled trial
    Research context
    Human research
    Sample size
    38 participants or samples
    Study population
    Patients with sarcoidosis and neuropathy symptoms

    PMID: 24136731

    DOI: 10.2119/molmed.2013.00122

Bibliographic references do not establish the identity, purity, safety, effectiveness, or suitability of this catalog item and are not use guidance. For legitimate laboratory and research use only; not for human or veterinary use.

Related catalog